Menu

Beyond 3-D: Recapitulating Nature for Optimal Bioproduction

FiberCell Systems invites you to join them for an educational webinar. 

Apr 15, 2018
The Scientist Creative Services Team

Beyond 3-D: Recapitulating Nature for Optimal Bioproduction from thescientistllc on Vimeo.

When cells are your factory, it’s imperative to ensure that they are kept under the right conditions throughout the life of the culture. Standard 2-D and 3-D culture systems, whether dish-, bag-, roller bottle-, or bioreactor-based, all share the same limitations; these cultures fail to keep the cells in tissue-like contact with neighboring cells, depriving them of important signaling cues. Hollow fiber bioreactors (HFBR) are able to promote a physiologically relevant interaction between cells while enabling product retrieval without perturbation. Learn more about HFBRs from FiberCell Systems, the sponsor of this webinar event, and learn how your standard methods are letting you down by design. Bring your questions and comments; FiberCell has the answers you seek.

Topics to be covered:

  • The spatial and nutritional constraints faced by standard cultures, and how HFBRs address them
  • Using HFBRs to generate monoclonal antibodies, exosomes, difficult-to-express proteins, and more

Meet the Speakers:

John Cadwell
CEO
FiberCell Systems

 

 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.